A recent study revealed decreased XPO4 hepatic expression with advancement of liver fibrosis through regulation of transforming growth factor beta (TGF-β)/SMAD3/SMAD4 -mediated HSC activation [7]. The gene discussed is TGFB1; the disease is Hepatic fibrosis.